Volta Finance Analyst Q&A: Robust cash reflecting the asset selection by AXA (LON:VTA) 2 October 2020
Gresham House Strategic ‘Strategic Public Equity’ approach pays off, outperforming its benchmarks (Interview)
Oncimmune Holdings plc Considerable potential for long term out-performance say Zeus Capital 10 February 2017
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Ruffer Investment Company reports October gains as equities and UK bonds lift performance 12 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Zigup PLC (ZIG.L): Investor Outlook Reveals a 36.98% Potential Upside with Robust Dividend Yield 14 November 2025
Wizz Air Holdings (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a 26.16% Potential Upside 14 November 2025
Trustpilot Group PLC (TRST.L) Stock Analysis: Examining a Potential 78% Upside Opportunity 14 November 2025
Temple Bar Investment Trust Pl (TMPL.L) Investor Outlook: A Solid Dividend Play with Robust Revenue Growth 14 November 2025
Volta Finance Analyst Q&A: Robust cash reflecting the asset selection by AXA (LON:VTA) 2 October 2020
Gresham House Strategic ‘Strategic Public Equity’ approach pays off, outperforming its benchmarks (Interview)
Oncimmune Holdings plc Considerable potential for long term out-performance say Zeus Capital 10 February 2017
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Ruffer Investment Company reports October gains as equities and UK bonds lift performance 12 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Zigup PLC (ZIG.L): Investor Outlook Reveals a 36.98% Potential Upside with Robust Dividend Yield 14 November 2025
Wizz Air Holdings (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a 26.16% Potential Upside 14 November 2025
Trustpilot Group PLC (TRST.L) Stock Analysis: Examining a Potential 78% Upside Opportunity 14 November 2025
Temple Bar Investment Trust Pl (TMPL.L) Investor Outlook: A Solid Dividend Play with Robust Revenue Growth 14 November 2025
Vertex Pharmaceuticals Incorporated – Consensus ‘buy’ rating and 7.3% Upside Potential 23 October 2024
Tissue Regenix well positioned to forge ahead with its strategic goals (Analyst Interview) 27 October 2020
Gresham House Strategic ‘Strategic Public Equity’ approach pays off, outperforming its benchmarks (Interview) 26 October 2020
INTERCONTINENTAL HOTELS GROUP Common Stock -10.8% potential downside indicated by Berenberg Bank 7 March 2024
International Consolidated Airlns Grp SA 33.9% potential upside indicated by RBC Capital Markets 7 March 2024
Syncona’s portfolio company, Freeline, releases positive data on gene therapy for Gaucher disease 19 January 2024
Travis Perkins Q4 trading in line with expectations, volume performance remains challenging 18 January 2024
Volta Finance Analyst Q&A: Robust cash reflecting the asset selection by AXA (LON:VTA) 2 October 2020
Oncimmune Holdings plc Considerable potential for long term out-performance say Zeus Capital 10 February 2017
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Ruffer Investment Company reports October gains as equities and UK bonds lift performance 12 November 2025
Record plc Transition Strategy Gains Traction as CEO Eyes Billion-Dollar Milestone (Video) 11 November 2025
Zigup PLC (ZIG.L): Investor Outlook Reveals a 36.98% Potential Upside with Robust Dividend Yield 14 November 2025
Wizz Air Holdings (WIZZ.L) Stock Analysis: Navigating Market Turbulence with a 26.16% Potential Upside 14 November 2025
Trustpilot Group PLC (TRST.L) Stock Analysis: Examining a Potential 78% Upside Opportunity 14 November 2025
Temple Bar Investment Trust Pl (TMPL.L) Investor Outlook: A Solid Dividend Play with Robust Revenue Growth 14 November 2025
